OMEROS CORP Advertising Expense
OMEROS CORP (OMER) reported Advertising Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-03-31
- OMEROS CORP advertising expense for fiscal 2025 was $0.00.
- OMEROS CORP advertising expense for fiscal 2024 was $0.00.
- OMEROS CORP advertising expense for fiscal 2023 was $0.00.
- OMEROS CORP advertising expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2023-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2022-12-31 | $0.00 10-K · filed 2025-03-31 | $3.20M 10-K · filed 2023-03-13 |
| 2021-12-31 | $800.00K 10-K · filed 2024-04-01 | $7.80M 10-K · filed 2022-03-01 |
| 2020-12-31 | $5.60M 10-K · filed 2023-03-13 | |
| 2019-12-31 | $8.00M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $2.50M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $300.00K 10-K · filed 2020-03-02 | $328.00K 10-K · filed 2018-03-01 |
| 2016-12-31 | $672.00K 10-K · filed 2019-03-01 | |
| 2015-12-31 | $885.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |